Background and Hypothesis: Genome-wide association and whole genome sequencing studies have uncovered over 20 novel Alzheimer's Disease (AD) risk genes. Many of these genes are involved with neuroinflammation. Neuroinflammation plays a pivotal role in disease development. CD33 and TREM2 are two immune pathway genes implicated in AD. We studied the association between peripheral blood expression of CD33 and TREM2, with cortical thickness -a marker of neurodegeneration in AD. We hypothesized that expression of some these genes would correlate with cortical atrophy in our pooled sample.
